SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Total Assets | ₹405 Cr | ₹378 Cr | ₹308 Cr | ₹184 Cr | ₹181 Cr |
What is the latest Total Assets ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Total Assets |
---|---|
Mar2024 | ₹405 Cr |
Mar2023 | ₹378 Cr |
Mar2022 | ₹308 Cr |
Mar2017 | ₹184 Cr |
Mar2016 | ₹181 Cr |
How is Total Assets of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Total Assets | % Change | |
---|---|---|---|
Mar2024 | ₹405 Cr | 7.10 | |
Mar2023 | ₹378 Cr | 22.58 | |
Mar2022 | ₹308 Cr | 67.59 | |
Mar2017 | ₹184 Cr | 1.81 | |
Mar2016 | ₹181 Cr | - |
Compare Total Assets of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,070.8 Cr | 1% | 42.4% | 81.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,068.0 Cr | 1.6% | -2.9% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,105.0 Cr | 1.5% | 10.4% | 51.9% | Stock Analytics | |
CIPLA | ₹122,016.0 Cr | 2.3% | 1.9% | 2.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,651.0 Cr | 5.7% | 14.1% | 15.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,942.0 Cr | 1.4% | 1.3% | 17% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | 1% |
42.4% |
81.3% |
SENSEX | 2.1% |
3.7% |
14.3% |
You may also like the below Video Courses